No Data
No Data
Chordia --- won the Innovation Award 2024.2Q sponsored by Mizuho Bank.
Chordia Therapeutics <190A> announced that it has been selected as a winning company in the 'Mizuho Innovation Award 2024.2Q', in which Mizuho Bank, a group company of Mizuho Financial Group <8411>, awards promising innovative companies every quarter. As a recipient of the 'Mizuho Innovation Award', the company will be provided with business opportunities with large corporations from Mizuho Bank.
The Growth Market 250 Index continues to battle the 75-day line, with interest turning to recent IPOs.
Expectations for a fresh start: This week, the emerging markets are expected to have a solid footing, as they dealt with profit-taking sales for short-term price increases. In the prime market this week, there is an expectation of over one trillion yen in sell-offs related to the earnings of listed ETFs. Although it is considered to be factored into the market to some extent, it may be a psychological burden due to last week's significant increase. As a result, there is a possibility of cyclical searches in the emerging markets. In the first half of last week, emerging markets underwent profit-taking.
Emerging markets outlook: Will the growth market 250 index continue to battle the 75-day line and shift focus to recent IPOs?
Trading volume stagnated in the market led by large cap shareholders and the emerging market fell this week. During the same period, while the Nikkei Stock Average increased by +3.36%, the growth market index and growth market 250 index decreased by -0.56% and -0.57%, respectively, making the emerging markets dominated by the main board. Funds continued to flow toward financial stocks and precision instrument stocks in the main board market, and on July 4, the Nikkei Stock Average and TOPIX both reached the highest level in history. The market capitalization of the main board market also reached a record high of 1000 for the first time.
Stocks hitting the upper or lower price limit in the afternoon session.
• Chordia Therapeutics <3136>, Econos <4288>, Azgent <4591>, Ribomic <7090>, Rigua <7776>, Cellseed <9214>, and Recovery International <190A> all hit the daily upper limit. • GMO Ad Partners <4784> and AHC Group <7083> both hit the daily lower limit. ※Includes temporary stops.
The Tokyo Stock Exchange's Gross Index continues to fall, with individual stock picking remaining lackluster for the day.
Tokyo Stock Exchange Growth Market Index 837.95 -13.47 / Volume 213,070,000 shares / Trading value 161.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 649.20 -12.04 / Volume 111,080,000 shares / Trading value 105.3 billion yen In today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index continued to decline. The number of rising stocks was 191, the number of falling stocks was 357, and the unchanged was 35. On June 28th, the Dow Jones Industrial Average fell by 45.20 dollars in the US market.
Three points to focus on in the afternoon ~ The semiconductor stock led to a rise to the 39,700 yen level for the first time since April.
In the afternoon of the 26th, there are three points to focus on in the trading: - Nikkei average rose sharply and continued to rise for three days. Semiconductor stocks led to a rise to the 39,700 yen level since April. - The dollar-yen rate is slightly positive, aiming for 160 yen. - The top contributors to the price increase are Toshiba<8035> and Advantest<6857>. Nikkei average rose sharply and continued to rise for three days, led by semiconductor stocks, reaching the 39,700 yen level since April. The Nikkei average rose significantly for the third consecutive day, closing 553.24 yen higher than the previous day (+1.41%).
No Data